Companion Spine raises $55 million to treat back pain from Bordeaux

2022-08-08 14:12:26 By : Mr. Daniel Tian

A new player in the development and marketing of innovative diagnostic and interventional surgery solutions for back pain, Companion Spine LLC, founded in August 2020 in Wilmington (Delaware/United States), announces on February 15 the raising of 55 million dollars (48.5 million euros).A large-scale transatlantic operation led by the investment fund Viscogliosi Brothers (VB), in New York, co-founded and managed by Anthony G. Viscogliosi, specialist on Wall Street in the financing of the orthopedic industry.Read also 4 min Implanet completes its refocusing on the correction of severe scoliosisSeen from the air, this financial operation could look like a disturbing Meccano since in the end this American fundraising will benefit the French company Companion Spine France, founded in September 2020 in Bordeaux, which must transform these funds into fuel for its development.Although it is 100% a daughter company of the American company, Companion Spine France will pilot the group's new international project."It must be understood that Companion Spine LLC is a holding company and that the head of the group is located in Bordeaux. It is from here that the development of the Companion Spine group will be decided. For having created and managed companies in the field of spinal therapies, I already knew the leaders of VB, and we started talking about this Companion Spine project in 2019, before the Covid crisis", rewinds for La Tribune Erick Cloix, director of Companion Spine France.Without going into all the details, the latter confirms that the capital increase of 22.4 million euros, from which Companion Spine France benefited on March 23, 2021 by a contribution from Companion Spine LLC, is part of this fundraising of 55 million dollars (48.5 million euros).If the Franco-American company develops clean technologies, it will also benefit from the sale by the American group Medtronic of a portfolio of 140 patents focused on pathologies of the spinal column that have entered its portfolio.Companion Spine France, which currently employs about ten people, should increase to nearly 25 next year.Read also 3 mn FineHeart hopes to test its wireless heart pump in humans by the end of 2022Companion Spine France is developing a set of therapeutic proposals that target degenerative disc disease (DDD) and lumbar stenosis (LSS)."We offer light surgical procedures with the installation of reversible devices. We intervene before the situation has degenerated and the vertebrae have been fused. Our device is very light, is installed in a few minutes, and is easily removed. It is reversible", emphasizes Erick CloixThe manager, who notably participated in the creation of the innovative company Implanet, in Martillac (Gironde), which develops devices in the context of severe scoliosis, specifies that Companion Spine does not intervene in this type of pathology and explains that in Bordeaux there is a truly original culture of treating spinal problems.An approach followed by Companion Spine France, which draws much inspiration from that of Bordeaux researcher Jacques Sénégas.Read also 7 mn Biotechnologies: Treefrog Therapeutics raises 64 million euros and will create its first subsidiary"Professor Sénégas understood before anyone else, thirty-five years ago, that it was necessary to intervene preventively on the spine, instead of waiting for it to be in a degenerative phase to operate. This is how "He has developed a strategy of light surgical intervention to preserve mobility, by intervening at the moment when the degeneration of the vertebral discs begins to cause the column to move. This type of intervention makes it possible to attenuate disordered movements or even to stop. Many practitioners made fun of him, but Jacques Sénégas was emulated and paved the way for the development of a new practice", reframes Erick Cloix.The company, which already has a subsidiary in the United States, in Memphis (Kentucky), and in Germany, has just obtained a first important recognition from the FDA, the American regulatory authority, which granted the Diam device the "Breakthrough device" status, in other words technology that could meet the still unmet needs of a category of patients.In addition to a real tradition in the treatment of spine pathologies, Erick Cloix is ​​pleased that the Port de la Lune is at the center of a rich network of aeronautics and space subcontractors, whose know-how correspond exactly to those who are expected to develop the technologies of Companion Spine France.Read also 4 mn The tracks of New Aquitaine to root biotechnologies in its territoryFrom Monday to Friday, at 7 p.m., receive the essential news from the Nouvelle Aquitaine regionLast step: confirm your registration in the email you have just received.Remember to check your junk mail.See you very soon on the La Tribune website and in our newsletters, La Tribune editorial staff.See you very soon on the La Tribune website and in our newsletters, La Tribune editorial staff.Discover all of La Tribune's newsletters The editorial staff of La TribuneAn email containing your login information has been sent.See you very soon on the La Tribune website and in our newsletters, La Tribune editorial staff.Subscribe to the New Aquitaine newsletterThe Bordeaux startup Loisirs Enchères in compulsory liquidationReal estate: the rag begins to burn between Bordeaux Métropole and developersForest fires: the Bassin d'Arcachon plan to save its tourist season“From September, we risk having an explosion in the number of collective proceedings”The Bordeaux group Human Immobilier absorbs the Côté Particuliers networkForest fires in Gironde: a brutal impact on tourist activity (6)Organic farming: “There will be a lot of deconversions if consumption does not pick up” (4)The timber industry hopes that the fires in Gironde will raise awareness of its cause (4)Forest fires in Gironde: more than 14,300 hectares burned and the aerial means in question (2)GPSO: ecologists make believe in the refusal of European financing of LGV (2)To be alerted by email of a reaction to this comment, please enter your email address below:Your email will not be displayed publicly.All fields are mandatory.Thank you for your comment.It will be visible soon subject to validation.